Flosonics Medical secures $20 million USD in Series C funding

Ontario Industry UpdatesOBIO News
Written By Arsheen Kaur

Flosonics Medical, a leader in wearable medical ultrasound, announced its Series C financing, raising $20 million USD. The round was led by New Leaf Venture Partners, with participation from previous investors Arboretum Ventures, Genesys Capital and iGan Partners. This new funding will support Flosonics as the company continues to innovate and drive market adoption of FloPatch, a first-in-class wearable Doppler ultrasound for hemodynamic assessments.

Flosonics Medical is an OBIO® member, an alumnus of our BDSP™, CAAP®, EAHN™, HealthMINT™ and WiHI programs, and presented at the OBIO® Investment Summit.

Arsheen Kaur
Previous

Ontario biotech start-ups get government funding and business support
Next

Through OBIO’s EAHN™, Trexo Plus Robotic Walker Enables Children with Physical Disabilities to Achieve Personalized Rehabilitation